A PK/PD Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes

NCT01965509 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: PEX168 or placebo

Sponsor

Jiangsu HengRui Medicine Co., Ltd.

Collaborators

[object Object]